Sequential causal inference in a single world of connected units
关联个体单一世界中的序贯因果推断AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要同时研究反事实干预和个体间网络依赖,直接对应因果推断与网络及干扰。
关联个体单一世界中的序贯因果推断AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
We consider adaptive designs for a trial involving N individuals that we follow along T time steps. We allow for the variables of one individual to depend on its past and on the past of other individuals. Our goal is to learn a mean outcome, averaged across the N individuals, that we would observe, if we started from some given initial state, and we carried out a given sequence of counterfactual interventions for $τ$ time steps. We show how to identify a statistical parameter that equals this mean counterfactual outcome, and how to perform inference for this parameter, while adaptively learning an oracle design defined as a parameter of the true data generating distribution. Oracle designs of interest include the design that maximizes the efficiency for a statistical parameter of interest, or designs that mix the optimal treatment rule with a certain exploration distribution. We also show how to design adaptive stopping rules for sequential hypothesis testing. This setting presents unique technical challenges. Unlike in usual statistical settings where the data consists of several independent observations, here, due to network and temporal dependence, the data reduces to one single observation with dependent components. In particular, this precludes the use of sample splitting techniques. We therefore had to develop a new equicontinuity result and guarantees for estimators fitted on dependent data. We were motivated to work on this problem by the following two questions. (1) In the context of a sequential adaptive trial with K treatment arms, how to design a procedure to identify in as few rounds as possible the treatment arm with best final outcome? (2) In the context of sequential randomized disease testing at the scale of a city, how to estimate and infer the value of an optimal testing and isolation strategy?